This trial will compare the rate of ipsilateral breast tumor recurrence in subjects treated with a single fraction of intra-operative radiation therapy using the Xoft Axxent Electronic Brachytherapy System to those treated with whole breast irradiation at 5 years of follow-up.
1 Primary · 0 Secondary · Reporting Duration: 5 years
50 Total Participants · 0 Treatment Group
Primary Treatment: Treatment · No Placebo Group · N/A
Age 18+ · Female Participants · 8 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: